Browse by Audience
Skip to content
Papers of the Week
ATP sensitive potassium (K) channel inhibition: A promising new drug target for migraine.
Authors
Abstract
Recently, the adenosine triphosphate (ATP) sensitive potassium channel opener levcromakalim was shown to induce migraine attacks with a far higher incidence than any previous provoking agent such as calcitonin gene-related peptide. Here, we show efficacy of ATP sensitive potassium channel inhibitors in two validated rodent models of migraine.